Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Research identifies new drug targets that promote recovery from spinal cord injury Pre-existing anti-cancer drugs that inhibit the DNA damage response are able to promote the regrowth of axons across damaged spinal cords and restore function to limbs.
20 September 2022 Research identifies new treatment target for CNS injury and neurological disease Potential target could treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.
12 July 2022 Research shows investigational drug fosters nerve repair after injury Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug can foster regeneration of damaged nerves after spinal trauma
04 July 2022 Largest genetic atlas for zebrafish ‘breakthrough’ for biomedical research A collection of genetic maps will enable scientists to better study key health conditions including cancers and heart disease.
15 March 2022 COVID-19 vaccination study opens at Great Ormond Street Hospital Patients at Great Ormond Street Hospital and Southampton Children's Hospital are taking part in research to work out how they respond to COVID-19 vaccination.
03 March 2022 Researchers find genetic 'fingerprints' of ancient migrations in modern-day United Arab Emirates Geneticists and archaeologists analysed 1,200 people from the United Arab Emirates and found genetic traces of population mixing spanning thousands of years.
16 February 2022 World-leading surgical research team gets fresh funding to save lives A world-leading global surgical research team led by the University of Birmingham has received £7 million to continue life-saving work in developing countries.
20 December 2021 University of Birmingham announces five new diabetes research studies The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
20 December 2021 Omicron may cause 100,000 cancelled operations in England this winter An additional 100,000 elective operations could be cancelled in England this winter as a result of the Omicron wave leading to increased hospital admissions.
02 November 2021 Urgent changes needed to global guidelines designed to stop surgical infection Wound infections are the most common problem after surgery, particularly in developing countries, but promised innovations to tackle the issue do not work and global guidance needs changing, a new study reveals.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
06 October 2021 One in seven patients miss cancer surgery during COVID lockdowns - study One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals.
04 October 2021 Higher rates of mutation alone are not to blame for age-related disease, study finds Small mutations accumulating in DNA are unlikely to be fully responsible for the ageing process, finds a new study carried out in collaboration with the University of Birmingham.